Are you thinking of starting a patient with juvenile arthritis on therapy with a TNF alpha inhibitor?

Does the patient have clear indications for TNF alpha inhibitor therapy?

Does the patient have a personal history of cancer?

Does the patient have risk factors for cancer, such as high dose therapy with other immunosuppressants?

Has the patient been instructed on how to reduce the chances of developing melanoma and other skin cancers?

Will you be regularly monitoring the patient for evidence of neoplasia?

Has the patient and family been instructed to report the onset of any new signs and symptoms?


Please fill out required fields.